GlassScriptPhysician profile
Ilyse Simone Lefkowicz
NPI 1164432043
$1,217.50
in general payments reported to CMS, 2019-2025
15 companies · $17.13 in 2025
The $17.13 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $154 · 2021: $193 · 2022: $297 · 2023: $117 · 2024: $57.51 · 2025: $17.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $315.79 | 2019-2022 | |
| Galderma Laboratories, L.P. | $158.42 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $129.56 | 2019-2022 | |
| Leo Pharma INC. | $126.04 | 2019-2021 | |
| Pfizer INC. | $115.48 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $62.90 | 2021-2024 | Winlevi, Absorica Ld |
| Revance Therapeutics, INC. | $61.03 | 2024-2025 | Daxxify |
| Dermira, INC. | $58.72 | 2019-2020 | |
| Merz North America, INC. | $50.99 | 2020-2021 | |
| Abbvie INC. | $38.39 | 2023 | |
| Aclaris Therapeutics, INC. | $36.89 | 2019 | |
| Encore Dermatology INC. | $18.47 | 2019 | |
| Incyte Corporation | $18.40 | 2022 | |
| Almirall LLC | $17.31 | 2019 | |
| Journey Medical Corporation | $9.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilyse Lefkowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.